Bone Pain Treatment Market Report 2026

Bone Pain Treatment Market Overview

• Bone Pain Treatment market size has reached to $6.05 billion in 2025 • Expected to grow to $8.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.2% • Growth Driver: The Increasing Prevalence Of Osteoporosis Is Driving The Growth Of The Market Due To Its Impact On Bone Density And Fracture Risk • Market Trend: Revolutionary Wearable Device Offers Targeted Therapy For Bone Health And Strength • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bone Pain Treatment Market?

Bone pain treatment refers to the medical interventions used to relieve discomfort or aching in the bones caused by conditions such as fractures, infections, cancer, or chronic diseases. It typically includes medications, physical therapy, and, in some cases, surgical procedures to address the underlying cause and alleviate pain. The main treatment types of bone pain treatment are pharmacological treatments, non-pharmacological treatments, and surgical interventions. Pharmacological treatments refer to the use of drugs or medications to prevent, manage, or cure diseases and medical conditions by targeting specific biological processes in the body. The drug classes used in treatment include analgesics, antidepressants, anticonvulsants, and corticosteroids. Common indications for bone pain treatment are injury, infection, myalgia, and tumors. These treatments are distributed through various channels such as direct sales, retail pharmacies, and online pharmacies. The end users include hospitals, clinics, and homecare settings.

What Is The Bone Pain Treatment Market Growth Forecast?

The bone pain treatment market size is expected to see strong growth in the next few years. It will grow to $8.58 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to opioid regulation, non-pharmacological therapy growth, oncology supportive care expansion, rehabilitation services growth, chronic pain management focus. Major trends in the forecast period include increased use of multimodal pain management, growth of non-opioid pain therapies, expansion of cancer-related bone pain treatment, adoption of physical and rehabilitative therapies, focus on personalized pain management.

What Is The Driver Of The Bone Pain Treatment Market?

The increasing prevalence of osteoporosis is expected to propel the growth of the bone pain treatment market going forward. Osteoporosis is a medical condition characterized by the loss of bone density and strength, leading to fragile bones that are more prone to fractures. Osteoporosis is rising due to the aging global population, as bone density naturally decreases with age, increasing the risk of the disease. Bone pain treatment helps osteoporosis by alleviating discomfort and improving mobility, which enhances the overall management of the condition and supports bone health maintenance. For instance, in April 2023, according to the AO Foundation, a Switzerland-based nonprofit organization, osteoporotic fractures occur every three seconds worldwide, affecting about 8.9 million people annually. In the U.S., these injuries already cost the healthcare system around USD 14 billion annually, and this economic burden is projected to more than double by 2025. Therefore, the increasing prevalence of osteoporosis is driving the growth of the bone pain treatment industry.

Key Players In The Global Bone Pain Treatment Market

Major companies operating in the bone pain treatment market are AbbVie Inc., Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Perrigo Company plc, Viatris Inc., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Indivior PLC, Pfizer Consumer Healthcare (Haleon), Kyowa Kirin Co. Ltd., Ferring Pharmaceuticals, Chiesi Farmaceutici S.p.A., Bausch Health Companies Inc., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi, Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd.

Global Bone Pain Treatment Market Trends and Insights

Major companies operating in the bone pain treatment market are focusing on developing innovative solutions, such as prescription wearable devices, to deliver targeted pain relief. Prescription wearable devices are medically approved gadgets worn on the body that deliver targeted therapies such as electrical stimulation or heat to help reduce bone pain by improving blood flow, decreasing inflammation, or blocking pain signals. For instance, in May 2025, Osteoboost Health Inc., a US-based medical equipment manufacturer, introduced Osteoboost, the first FDA-cleared wearable device designed for low bone density. This wearable belt provides targeted, low-amplitude, high-frequency vibration therapy (20–40 Hz) to the spine and hips, aimed at slowing bone density and strength loss in postmenopausal women with osteopenia. Worn for 30 minutes daily during regular activities, the device is clinically proven to help reduce the decline in bone strength and volumetric bone density, with no significant adverse events reported. The design includes a motorized vibration pack, pressure sensor, and accelerometers to ensure safe and effective therapy delivery.

What Are Latest Mergers And Acquisitions In The Bone Pain Treatment Market?

In November 2023, Boston Scientific Corporation, a US-based biotechnology company, acquired Relievant Medsystems Inc. for $850 million. With this acquisition, Boston Scientific Corporation aims to expand its chronic pain portfolio and strengthen its leadership in interventional pain management by providing innovative, FDA-cleared therapies that improve patient access and outcomes. Relievant Medsystems Inc. is a US-based company that specializes in providing treatment for chronic low back pain, specifically targeting a condition known as vertebrogenic pain.

What Defines the Bone Pain Treatment Market?

The bone pain treatment market includes revenues earned by entities by providing services such as pharmacological therapy services, physical therapy and rehabilitation services, surgical intervention services, pain management clinics, and diagnostic imaging and evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bone pain treatment also includes sales of acetaminophen, ibuprofen, naproxen, morphine, oxycodone, alendronate, and prednisone. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bone Pain Treatment Market Report 2026?

The bone pain treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bone pain treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.